Infantile hemangioma is originated from placental trophoblast, fact or fiction?

Medical Hypotheses

Volumn 71, Issue 3, 2008, Pages 444-448

  Sun, Zhi Yong ^a   Yi, Cheng Gang ^b   Zhao, Huan ^a   Yin, Guo Qian ^a   Gao, Ming ^a   Liu, Yan Bin ^a   Qin, Jia De ^a   Wang, Shou Feng ^a   Guo, Shu Zhong ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

AMNIOSCOPY; ARTICLE; CHORION VILLUS SAMPLING; FETUS CIRCULATION; GENE EXPRESSION; GESTATIONAL AGE; HEMANGIOMA; HUMAN; INCIDENCE; PRIORITY JOURNAL; TROPHOBLAST;

ENDOTHELIAL CELLS; FEMALE; HEMANGIOMA; HUMANS; INFANT, NEWBORN; PLACENTA; TROPHOBLASTS;

EID: 47549089027     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.03.013     Document Type: Article

References (20)

1. Sundine M.J., and Wirth G.A. Hemangiomas: an overview. Clin Pediatr (Phila) 46 (2007) 206-221
2. Drolet B.A., Esterly N.B., and Frieden I.J. Hemangiomas in children. New Engl J Med 341 (1999) 173-181
3. Bree A.F., Siegfried E., Sotelo-Avila C., et al. Infantile hemangiomas: speculation on placental trophoblastic origin. Arch Dermatol 137 (2001) 573-577
4. Wallenburg H.C.S. Chorioangioma of the placenta. Obstet Gynecol Surv 26 (1971) 411-425
5. Burton B.K., Schulz C.J., Angle B., et al. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn 15 (1995) 209-214
6. Barzilay D., Metzker A., and Brenner S. Some considerations on hemangioma. Skinmed 1 (2002) 47-49
7. North P.E., Waner M., Mizeracki A., et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31 (2000) 11-22
8. North P.E., Waner M., Mizeracki A., et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137 (2001) 559-570
9. Barnes C.M., Huang S., Kaipainen A., et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 102 (2005) 19097-19102
10. Metz B.J., Rubenstein M.C., Levy M.L., et al. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol 140 (2004) 867-870
11. Simpson J.L. Choosing the best prenatal screening protocol. New Engl J Med 353 (2005) 2068-2070
12. Campbell S., Park J.H., Rowe J., et al. Chorionic villus sampling as a source of trophoblasts. Placenta 28 (2007) 1118-1122
13. Post M.C., Letteboer T.G., Mager J.J., et al. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 128 (2005) 2485-2489
14. Wilmshurst P.T., Nightingale S., Walsh K.P., et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356 (2000) 1648-1651
15. Anzola G.P., Frisoni G.B., Morandi E., et al. Shunt-associated migraine responds favorably to atrial septal repair: a casecontrol study. Stroke 37 (2005) 430-434
16. Ritter M.R., Reinisch J., Friedlander S.F., et al. Myeloid cells in infantile hemangioma. Am J Pathol 168 (2006) 621-628
17. Clark D.E., Smith S.K., He Y., et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 59 (1998) 1540-1548
18. Barrio V.R., and Drolet B.A. Treatment of hemangiomas of infancy. Dermatol Ther 18 (2005) 151-159
19. Jia J., Zhao Y.F., and Zhao J.H. Potential roles of allograft inflammatory factor-1 in the pathogenesis of hemangiomas. Med Hypotheses 68 (2007) 288-290
20. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974